CIK 0001314102 · Non-accelerated filer<br>Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262774444
- Phone
- 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $52,258
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$52,258. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-23 | Duker Jay S. President and CEO | Other disposition | −76,766 | $13.11 | $1.0M | 986 |
| 2026-03-23 | Duker Jay S. President and CEO | Other acquisition | +76,766 | $13.11 | $1.0M | 177,431 |
| 2026-03-23 | Duker Jay S. President and CEO | Other disposition · Stock Option (Right to Buy) | −52,500 | $8.75 | $459K | 7,800 |
| 2026-03-23 | Duker Jay S. President and CEO | Other acquisition · Stock Option (Right to Buy) | +52,500 | $8.75 | $459K | 52,500 |
| 2026-03-23 | Duker Jay S. President and CEO | Other disposition · Stock Option (Right to Buy) | −97,500 | $9.57 | $933K | 82,500 |
| 2026-03-23 | Duker Jay S. President and CEO | Other acquisition · Stock Option (Right to Buy) | +97,500 | $9.57 | $933K | 97,500 |
| 2026-03-16 | Duker Jay S. President and CEO | Purchase | +1,500 | $13.15 | $20K | 100,665 |
| 2026-03-04 | Ribeiro Ramiro Chief Medical Officer | Option exercise 10b5-1 | +2,438 | $8.26 | $20K | 2,438 |
| 2026-03-04 | Ribeiro Ramiro Chief Medical Officer | Sale 10b5-1 | −2,438 | $17.87 | $44K | 0 |
| 2026-03-04 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,438 | 82,875 | ||
| 2026-03-02 | Elston George Chief Financial Officer | Gift | −5,000 | 87,818 | ||
| 2026-03-02 | Elston George Chief Financial Officer | Gift | +5,000 | 30,000 | ||
| 2026-02-17 | Ribeiro Ramiro Chief Medical Officer | Option exercise 10b5-1 | +2,437 | $8.26 | $20K | 2,437 |
| 2026-02-17 | Ribeiro Ramiro Chief Medical Officer | Sale 10b5-1 | −2,437 | $15.00 | $37K | 0 |
| 2026-02-17 | Ribeiro Ramiro Chief Medical Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −2,437 | 85,313 | ||
| 2026-01-06 | Duker Jay S. President and CEO | Option exercise | +20,793 | 87,806 | ||
| 2026-01-06 | Duker Jay S. President and CEO | Shares withheld for taxes | −10,054 | $16.86 | $170K | 77,752 |
| 2026-01-06 | Duker Jay S. President and CEO | Option exercise · Restricted Stock Units | −20,793 | 0 | ||
| 2026-01-06 | Lurker Nancy Director | Option exercise | +75,133 | 294,346 | ||
| 2026-01-06 | Lurker Nancy Director | Option exercise · Restricted Stock Units | −75,133 | 0 |
Page 2 of 18 · 352 trades